Skip to content

Clinical Effect of Laser Acupuncture on Improving Cancer-related Fatigue

Clinical Effect of Laser Acupuncture on Improving Cancer-related Fatigue

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04947969
Enrollment
100
Registered
2021-07-01
Start date
2021-07-01
Completion date
2023-07-31
Last updated
2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related Fatigue

Keywords

Laser acupuncture

Brief summary

The aim of this study is to examine the clinical effect of laser acupuncture on improving cancer-related fatigue

Detailed description

This study adopted a randomized controlled design, 2-arm trial cross-over study. All eligible patients included in the study agreed to participated and signed the informed consent from and the study procedures were approved by the ethical committee of Taichung Tzu Chi general hospital (REC110-09). Patients were recruited from the hematology oncology department of Taichung Tzu Chi general hospital. After random assignment to 2 groups, patients in the RS and SR groups will receive real and shame laser acupuncture. Before laser acupuncture, one week later, we will evaluate the patient-reported cancer-related fatigue index and other co-morbid symptoms.

Interventions

DEVICElaser acupuncture

This study will use German-made low-level laser pen (Al-Ga-As diode laser, 810nm, NIR, Physiolaser Olympic Basic, RJ laser). The parameters are power of 100mW, frequency of Bahr, apply on acupoint. Well will irradiate each point for 2 J. Each patient will receive this treatment six times for one week.

Sponsors

Taichung Tzu Chi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

After random assignment to 2 groups, patients in the RS and SR groups will receive real and shame laser acupuncture (single blinding), six consecutive times every day.

Intervention model description

Randomized controlled, double blind, cross-over study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adults between 18 to 85 years old * Patients who signed the informed consent form * Patients who have been given a diagnosis of cancer * Able to communicate verbally and completely fill the questionnaires

Exclusion criteria

* Patients who have given a diagnosis of cognitive impairment are unable to completely the questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Cancer-related fatigue evaluation30 minutesICD-10 Fatigue Criteria Brief Fatigue inventory-Taiwan Form
Cancer-related fatigue Assessment15 minutesBrief Fatigue Inventory-Taiwanese (BFI-T)

Secondary

MeasureTime frameDescription
Quality of Life Assessments15 minutesFunctional Assessment of Cancer Therapy-general (FACT-G7)
Symptoms distress Assessments20 minutesTaiwanese Version of the M.D. Anderson symptom Inventory (MDASI-T)

Contacts

Primary ContactWu Chung Hung, Dr.
wuchunghung1@gmail.com886-911856726
Backup ContactWu Chung Hung
wuchunghung1@gmail.com886-911856726

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026